Home › Oropharyngeal Cancer › Illinois › Naperville
Oropharyngeal Cancer clinical trials in Naperville, IL
4 studies for Oropharyngeal Cancer are looking for participants at sites in and around Naperville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPhase 2
- Rush MD Anderson Cancer Center at Rush Lisle, Lisle · 4 mi away
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Northwestern Medicine Cancer Center Warrenville, Warrenville · 3 mi away
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Northwestern Medicine Cancer Center Warrenville, Warrenville · 3 mi away
Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
RecruitingPhase 2
- Northwestern Medicine Warrenville, Warrenville · 3 mi away
Oropharyngeal Cancer trials in other cities
- Atlanta, GA8 studies
- Edison, NJ8 studies
- Chicago, IL7 studies
- New York City, NY6 studies
- Queens, NY5 studies
- St. Louis, MO5 studies
- Tampa, FL5 studies
- Kansas City, MO5 studies
- Pittsburgh, PA5 studies
- Omaha, NE5 studies
- Milwaukee, WI5 studies
- Los Angeles, CA5 studies
Other studies in Naperville
- Non-Small Cell Lung Cancer16 studies
- Lung Cancer13 studies
- Heart Failure12 studies
- Prostate Cancer10 studies
- Breast Cancer9 studies
- Cardiovascular Disease8 studies
- Macular Degeneration6 studies
- Geographic Atrophy6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Pancreatic Cancer6 studies
- Melanoma5 studies
- Cancer (all types)5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.